findmyKOL

Daniel Wallman, MD

Basic profile

Boston University

ORCID↗NPI↗
✓ Full record
RegionBoston, MA · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH funding2023–2023Why? →

Daniel Wallman is a Respiratory physician affiliated with Boston University. OpenAlex indexes 16 publications with 393 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex, matched via ORCID.

393citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2023–2023

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

725 Albany Street, Suite 9b
Shapiro Bldg
Boston, MA 021182526

Telephone

617-638-7480

Provider last certified this registry record 9 Apr 2024.

View the NPPES registry record

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    87.6%
    beta2-Adrenergic Agonist43.8%
    Albuterol Sulfate Hfa70%Ventolin Hfa30%
    Part D<11 patients
    Corticosteroid21.9%
    Fluticasone Propionate100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    12.4%
    Proton pump inhibitor12.4%
    Omeprazole100%
    Part D<11 patients
Where care is delivered (Part B), 2024100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 2023–2023 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”